The purpose of this study is to evaluate the effect of givosiran on the pharmacokinetics of the 5-probe cocktail of midazolam, caffeine, losartan, omeprazole, and dextromethorphan, and their metabolites, in asymptomatic patients with Acute Intermittent Porphyria.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Profile of Pharmacokinetics (PK) of Cytochrome P450 (CYP) probe cocktail
Timeframe: Days 1 and 36
Profile of Pharmacokinetics (PK) of Cytochrome P450 (CYP) probe cocktail
Timeframe: Days 1 and 36